212 related articles for article (PubMed ID: 26418892)
1. Effectiveness of Influenza Vaccination for Individuals with Chronic Obstructive Pulmonary Disease (COPD) in Low- and Middle-Income Countries.
Lall D; Cason E; Pasquel FJ; Ali MK; Narayan KM
COPD; 2016; 13(1):93-9. PubMed ID: 26418892
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients.
Wongsurakiat P; Lertakyamanee J; Maranetra KN; Jongriratanakul S; Sangkaew S
J Med Assoc Thai; 2003 Jun; 86(6):497-508. PubMed ID: 12924797
[TBL] [Abstract][Full Text] [Related]
3. Prevention and control of influenza in persons with chronic obstructive pulmonary disease.
Plans-Rubió P
Int J Chron Obstruct Pulmon Dis; 2007; 2(1):41-53. PubMed ID: 18044065
[TBL] [Abstract][Full Text] [Related]
4. Influenza vaccination for patients with chronic obstructive pulmonary disease: Implications for pharmacists.
Arabyat RM; Raisch DW; Bakhireva L
Res Social Adm Pharm; 2018 Feb; 14(2):162-169. PubMed ID: 28533080
[TBL] [Abstract][Full Text] [Related]
5. Influenza cost and cost-effectiveness studies globally--a review.
Peasah SK; Azziz-Baumgartner E; Breese J; Meltzer MI; Widdowson MA
Vaccine; 2013 Nov; 31(46):5339-48. PubMed ID: 24055351
[TBL] [Abstract][Full Text] [Related]
6. Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.
Ott JJ; Klein Breteler J; Tam JS; Hutubessy RC; Jit M; de Boer MR
Hum Vaccin Immunother; 2013 Jul; 9(7):1500-11. PubMed ID: 23732900
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccination and reduction in risk of ischemic heart disease among chronic obstructive pulmonary elderly.
Huang CL; Nguyen PA; Kuo PL; Iqbal U; Hsu YH; Jian WS
Comput Methods Programs Biomed; 2013 Aug; 111(2):507-11. PubMed ID: 23769164
[TBL] [Abstract][Full Text] [Related]
8. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination.
Menon B; Gurnani M; Aggarwal B
Int J Clin Pract; 2008 Apr; 62(4):593-8. PubMed ID: 18284444
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.
Sanei F; Wilkinson T
Ther Adv Respir Dis; 2016 Aug; 10(4):349-67. PubMed ID: 27193567
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease.
Anar C; Bicmen C; Yapicioglu S; Unsal I; Halilcolar H; Yilmaz U
New Microbiol; 2010 Apr; 33(2):117-27. PubMed ID: 20518273
[TBL] [Abstract][Full Text] [Related]
11. Influenza Vaccine Effectiveness in Preventing Hospitalizations in Older Patients With Chronic Obstructive Pulmonary Disease.
Gershon AS; Chung H; Porter J; Campitelli MA; Buchan SA; Schwartz KL; Crowcroft NS; Campigotto A; Gubbay JB; Karnauchow T; Katz K; McGeer AJ; McNally JD; Richardson DC; Richardson SE; Rosella LC; Simor AE; Smieja M; Zahariadis G; Kwong JC
J Infect Dis; 2020 Jan; 221(1):42-52. PubMed ID: 31549165
[TBL] [Abstract][Full Text] [Related]
12. Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: A systematic review from 2012 to 2022.
Gharpure R; Chard AN; Cabrera Escobar M; Zhou W; Valleau MM; Yau TS; Bresee JS; Azziz-Baumgartner E; Pallas SW; Lafond KE
PLoS Med; 2024 Jan; 21(1):e1004333. PubMed ID: 38181066
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacoeconomics of vaccinations in chronic obstructive pulmonary disease].
Słominski JM; Kubiak A
Pol Merkur Lekarski; 2004 May; 16 Suppl 1():83-5. PubMed ID: 15524025
[TBL] [Abstract][Full Text] [Related]
14. WHO guide on the economic evaluation of influenza vaccination.
Newall AT; Chaiyakunapruk N; Lambach P; Hutubessy RCW
Influenza Other Respir Viruses; 2018 Mar; 12(2):211-219. PubMed ID: 29024434
[TBL] [Abstract][Full Text] [Related]
15. Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease.
Vila-Córcoles A; Ochoa O; de Diego C; Valdivieso A; Herreros I; Bobé F; Alvarez M; Juárez M; Guinea I; Ansa X; Saún N
Int J Clin Pract; 2008 Jan; 62(1):10-7. PubMed ID: 17573840
[TBL] [Abstract][Full Text] [Related]
16. Management of influenza in patients with asthma or chronic obstructive pulmonary disease.
Nathan RA; Geddes D; Woodhead M
Ann Allergy Asthma Immunol; 2001 Dec; 87(6):447-54, 487. PubMed ID: 11770690
[TBL] [Abstract][Full Text] [Related]
17. [Vaccination of COPD patients: From guidelines to routine practise].
Blanchard E; Piquet J; Piperno D; Pinet C; Stach B; Roche N
Rev Mal Respir; 2018 Dec; 35(10):999-1001. PubMed ID: 30429091
[No Abstract] [Full Text] [Related]
18. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study.
Sung LC; Chen CI; Fang YA; Lai CH; Hsu YP; Cheng TH; Miser JS; Liu JC
Vaccine; 2014 Jun; 32(30):3843-9. PubMed ID: 24837769
[TBL] [Abstract][Full Text] [Related]
19. Effect of annual influenza vaccination on reducing lung cancer in patients with chronic obstructive pulmonary disease from a population-based cohort study.
Chen KY; Wu SM; Liu JC; Lee KY
Medicine (Baltimore); 2019 Nov; 98(47):e18035. PubMed ID: 31764822
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Influenza Vaccination in Chronic Obstructive Pulmonary Disease Patients and Impact on the Risk of Severe Exacerbations.
Garrastazu R; García-Rivero JL; Ruiz M; Helguera JM; Arenal S; Bonnardeux C; León C; Llorca J; Santibañez M
Arch Bronconeumol; 2016 Feb; 52(2):88-95. PubMed ID: 26526292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
